Windlas Biotech Ltd
NSE:WINDLAS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Windlas Biotech Ltd
NSE:WINDLAS
|
IN |
|
Fuyao Glass Industry Group Co Ltd
OTC:FIGIF
|
CN |
|
L
|
Labiana Health SA
MAD:LAB
|
ES |
|
M
|
Metacon AB (publ)
F:M16
|
SE |
|
C
|
CDW Corp
DUS:CDW
|
US |
|
Greene County Bancorp Inc
NASDAQ:GCBC
|
US |
|
Ebusco Holding NV
F:8J30
|
NL |
|
DBS Group Holdings Ltd
F:DEV
|
SG |
|
R
|
Royal Gold Inc
F:RG3
|
US |
|
C
|
Commax Co Ltd
KOSDAQ:036690
|
KR |
|
C
|
Columbia Sportswear Co
XMUN:CUW
|
US |
|
M
|
Muang Thai Insurance PCL
SET:MTI
|
TH |
|
R
|
Randstad NV
AEX:RAND
|
NL |
|
Y
|
Yamaha Corp
F:YHA
|
JP |
|
Osai Automation System SpA
F:6JG
|
IT |
Intrinsic Value
Is WINDLAS undervalued or overvalued?
See the intrinsic value estimate for Windlas Biotech Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
WINDLAS looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with WINDLAS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Windlas Biotech Does
Windlas Biotech makes finished pharmaceutical products for other drug companies and also sells its own branded medicines in India. Its core work is contract development and manufacturing of tablets, capsules, and other solid-dose medicines, where customers hire Windlas to develop a formula, manufacture the product, and package it under the customer’s brand. It also supplies selected products through its own domestic distribution network, which gives it a mix of contract and branded business.
- Headquarters
- India IN
- IPO date
- Aug 16, 2021
Earnings Waterfall
Windlas Biotech Ltd
The intrinsic value for Windlas Biotech Ltd (WINDLAS) under the Base Case is hidden INR.
Compared with the current market price of 872.5 INR, the stock appears hidden.